A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to ...
JAAA: $46.41 million (5.7% of AUM) VUG: $40.11 million (4.9% of AUM) DFLV: $32.03 million (3.9% of AUM) JCPB: $28.13 million (3.45% of AUM) AMZN: $27.70 million (3.4% of AUM) As of Tuesday afternoon, ...
Today, Zacks Investment Ideas feature highlights iShares Biotechnology ETF IBB, Novartis NVS, Pfizer PFE and Eli Lilly’s LLY.
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...
Key Points Interested in iShares Biotechnology ETF? Here are five stocks we like better. The iShares Nasdaq Biotechnology ETF ...
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Biotechnology ETF (Symbol: IBB) where we have detected an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results